Hims & Hers Health (HIMS) Total Current Liabilities (2019 - 2026)

Hims & Hers Health's (HIMS) quarterly Total Current Liabilities came in at $618.8 million in Q1 2026, up 120.71% year-on-year from $280.4 million in Q1 2025, and up 53.0% quarter-over-quarter from $404.4 million in Q4 2025.

Hims & Hers Health (HIMS) Total Current Liabilities (2019 - 2026) Analysis & Trends

Hims & Hers Health has disclosed Total Current Liabilities across 8 years of filings, most recently posting $618.8 million for Q1 2026.

  • Total Current Liabilities for Q1 2026 came in at $618.8 million, up 120.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $618.8 million (up 120.71% YoY), and the FY2025 annual result was $404.4 million, up 82.7% from the prior year.
  • Total Current Liabilities came in at $618.8 million for Q1 2026 at Hims & Hers Health, up from $404.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $618.8 million in Q1 2026 to a low of $47.9 million in Q4 2022.
  • The 5-year median for Total Current Liabilities is $93.3 million (2024), against an average of $183.3 million.
  • Across the five-year window, Total Current Liabilities tumbled 39.48% in 2022 and jumped 200.42% in 2025, its largest moves.
  • Hims & Hers Health's Total Current Liabilities stood at $47.9 million in 2022, then surged by 84.54% to $88.5 million in 2023, then surged by 150.22% to $221.4 million in 2024, then soared by 82.7% to $404.4 million in 2025, then soared by 53.0% to $618.8 million in 2026.
  • The last three Total Current Liabilities figures came in at $618.8 million (Q1 2026), $404.4 million (Q4 2025), and $450.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 13.53 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 2.05 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 831.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 1.66 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 599.50 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 333.17 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 618.78 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 149.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 618.78 Mn
Dec 31, 2025 404.43 Mn
Sep 30, 2025 450.79 Mn
Jun 30, 2025 272.23 Mn
Mar 31, 2025 280.36 Mn
Dec 31, 2024 221.37 Mn
Sep 30, 2024 152.65 Mn
Jun 30, 2024 108.67 Mn
Mar 31, 2024 93.32 Mn
Dec 31, 2023 88.47 Mn
Sep 30, 2023 82.55 Mn
Jun 30, 2023 66.55 Mn
Mar 31, 2023 56.28 Mn
Dec 31, 2022 47.94 Mn
Sep 30, 2022 66.82 Mn
Jun 30, 2022 55.62 Mn
Mar 31, 2022 48.50 Mn
Dec 31, 2021 79.22 Mn
Sep 30, 2021 52.50 Mn
Jun 30, 2021 27.34 Mn